AtriAmp Commercialization
Postoperative arrhythmia monitoring after cardiac surgery
CommercialActive
Key Facts
Indication
Postoperative arrhythmia monitoring after cardiac surgery
Phase
Commercial
Status
Active
Company
About Atrility Medical
Atrility Medical addresses a critical gap in post-cardiac surgery care by commercializing the AtriAmp, an FDA-cleared medical device that delivers continuous atrial electrograms to the bedside monitor. This technology provides clinicians with the gold-standard signal for arrhythmia diagnosis in real-time, potentially reducing diagnostic delays, preventing inappropriate treatments, and improving patient outcomes. The company targets pediatric and adult cardiac ICUs, leveraging strong clinical testimonials and published data showing improved diagnostic accuracy and confidence. Atrility appears to be a commercial-stage, private company driving adoption of its novel monitoring solution.
View full company profile